Answers are grounded in this paper and cite their sources.
Elevated plasma beta thromboglobulin (betatg) and decreased intracellular platelet betatg were found in patients with various myeloproliferative disorders. In secondary thrombocytosis, similar, but less marked changes were found. The abnormalities were increased during episodes of clinical thrombosis and could be suppressed in two-thirds of cases by aspirin therapy.
No takes yet. Share an insight, caveat, or question.
Boughton et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: